The American Heart Association (AHA) accepted an $11 million donation from a drug company that produces a thrombolytic - a drug that breaks down blood clots - while preparing its guidelines on stroke management.
The American Heart Association (AHA) accepted an $11 million donation from a drug company that produces a thrombolytic - a drug that breaks down blood clots - while preparing its guidelines on stroke management.